Drug Industry – Page 3

Pharmaceutical Giants Bristol Myers Squibb and Kyowa Kirin Announce 119 Layoffs in New Jersey Amid Restructuring Efforts

3 months ago talkbio0Tagged cost-cutting, Drug Industry, Kirin, Kyowa, Myers, New Jersey, restructuring, squibb

Bristol Myers Squibb, Kyowa Kirin, layoffs, New Jersey, restructuring, pharmaceutical industry, cost-cutting, workforce reduction

Novo Nordisk Projects Slower Growth for 2025 Despite Wegovy’s Strong Q4 Performance

3 months ago talkbio0Tagged Drug Industry, Growth, Nordisk, Obesity, Sales - occupational activity, Wegovy

Novo Nordisk, Wegovy, obesity drugs, sales growth, 2025 outlook, pharmaceutical industry

Pharmaceutical Industry Warns of Drug Shortages and Price Hikes Due to Trump’s New Tariffs

3 months ago talkbio0Tagged Active, APIs, chain disruption, Drug Industry, Drug shortages, Groups, Increased, Prices, TNFRSF19 gene, Trump tariffs

Trump tariffs, drug shortages, price increases, pharmaceutical industry, trade groups, supply chain disruption, generic drugs, active pharmaceutical ingredients (APIs)

Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance

3 months ago talkbio0Tagged Administration occupational activities, Astellas Pharma, Drug Industry, financial results, restructuring

Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry

Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs

3 months ago talkbio0Tagged Drug Industry, Drug shortages, Health care facility, Import, Medical Devices, medical supply chain, Trump tariffs

Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes

Novartis Reports Strong Financial Performance in 2024, Validating Pure-Play Strategy

3 months ago talkbio0Tagged Drug Industry, earnings, financial performance, Focal, Novartis, pure-play strategy, therapeutic areas

Novartis, earnings, pure-play strategy, pharmaceutical industry, financial performance, R&D focus, core therapeutic areas

AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction

3 months ago talkbio0Tagged Administration occupational activities, AstraZeneca, Drug Industry, Economic Growth, Government, Investments, Labor (Childbirth), Manufacturing, UK, Vaccines

AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry

Julie Kim to Succeed Christophe Weber as Takeda’s CEO in 2026

3 months ago talkbio0Tagged biopharmaceutical company, CEO, Christophe Weber, Drug Industry, Kim, Leadership, succession, Takeda, Transition Mutation

Takeda, Julie Kim, Christophe Weber, CEO succession, pharmaceutical industry, leadership transition, biopharmaceutical company

Sage Therapeutics Rejects Biogen’s Acquisition Bid, Initiates Strategic Review

3 months ago talkbio0Tagged Acquisition, Biogen, Depression, Postpartum, Drug Industry, M&A, strategic alternatives, Zurzuvae

Sage Therapeutics, Biogen, acquisition rejection, strategic alternatives, ZURZUVAE, postpartum depression, pharmaceutical industry, M&A

Novo Nordisk’s Obesity Drug Breakthrough: 22% Weight Loss at Week 36 Boosts Stock by 11%

3 months ago talkbio0Tagged 22%, amycretin, Drug Industry, next-gen, Nordisk, Obesity, semaglutide, Stock Surge, Weight Loss

Novo Nordisk, Obesity drug, 22% weight loss, Stock surge, Next-gen obesity treatment, Amycretin, Semaglutide, Pharmaceutical industry